ARDELYX, INC. Contract Liability (Deferred Revenue)
ARDELYX, INC. (ARDX) had Contract Liability (Deferred Revenue) of $6.74 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Contract with Customer, Liability, Current $6.74M.
- 2026-03-31: Contract with Customer, Liability, Current $3.25M.
- 2025-12-31: Contract with Customer, Liability, Current $1.21M.
- 2025-09-30: Contract with Customer, Liability, Current $6.58M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $6.74M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.25M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $1.21M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $6.58M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $6.28M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $10.91M 10-Q · filed 2026-04-30 |
| 2024-12-31 | $10.69M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $7.27M 10-Q · filed 2025-10-30 |
| 2024-06-30 | $10.83M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $6.59M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $7.18M 10-K · filed 2026-02-19 |
| 2023-09-30 | $4.07M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $5.96M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $5.54M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $4.21M 10-K · filed 2024-02-22 |
| 2022-09-30 | $4.00M 10-Q · filed 2022-11-03 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-02 |
| 2021-09-30 | $527.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.41M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $2.72M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.18M 10-K · filed 2022-02-28 |
| 2018-12-31 | $1.00M 10-K · filed 2020-03-06 |
| 2018-09-30 | $1.00M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.00M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.00M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |